© Boston Life Sciences. 2012. All rights reserved. Important Legal Notice

Home | Company Profile | Product Pipeline | Patient Center | Investor Relations | Contact Us

Breaking News: Boston Life Sciences, Inc. Elects William L.S. Guinness to Its Board of Directors. more >

Boston Life Sciences Ends ALTROPANE(R) POET-1 Phase III Trial Early to Evaluate Full Data Set. more >

Boston Life Sciences Moves into New Headquarters. more >

Boston Life Sciences Announces $12.7 Million Private Placement of Common Stock. more >



This site is protected by www.LetterDash.com, the cease and desist letter platform.
If you violate any of our copyrights or trademarks, you will receive an
official letter from our attorneys via LetterDash™.


We proudly engaged our marketing firm through:
Great Agencies - Marketplace for SEO and Digital Marketing Companies
(888) 222-8311
Located in the Sunnyvale City Center
support@greatagencies.com

Boston Life Sciences, Inc. is a Biotechnology Company Engaged in the Research and Clinical Development of Novel Diagnostic and Therapeutic Products for Central Nervous System Diseases.